Matching Biomarkers to Disease Biology & Therapy
Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment.
Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment.
Dr. Lori Rink, Fox Chase Cancer Center, and Dr. Inga-Marie Schaefer, Brigham & Women’s Hospital, are two researchers who are making discoveries in their respective laboratories to uncover the unique biomarkers in GIST that will be future drug targets.
A recent study published in the Journal of Translational Medicine, presents important research findings for the 10-15% of GIST patients who lack mutations in KIT, PDGFRA, SDHX or RAS pathway indicators, the primary oncogenic [...]